Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for Ischemia/Reperfusion Injury in CABG
NCT01295567Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dipyridamole in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Dec 2009; status: completed.
02
Drugs
dipyridamole
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01295567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295567.